Interactive Models on Therapy Area

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | » »|

Type Product title / description Pub Price
Interactive Model
Interactive Model

Allergic Rhinitis Market Forecast

Overview of the current and future allergic rhinitis market, including in-depth analysis of changes in the market, 10 year indication specific sales forecasts of key classes, and a 10 year interactive patient based forecast for immunotherapy.

Published By Datamonitor
14 Jul 2010 $15200
Buy
Interactive Model
Interactive Model

Alzheimer's Disease Market Forecast

Assessment of the current and future Alzheimer’s disease market using a patient-based forecasting methodology. The analysis is designed to understand the dynamics of the Alzheimer’s disease drug market, with a particular focus on pipeline therapies.

Published By Datamonitor
18 Nov 2011 $6400
Buy
Interactive Model
Interactive Model

Antibacterials: Market Forecast

10-year forecast for the antibacterial drugs market across the US, Japan and 5EU (France, Germany, Italy, Spain, UK).

Published By Datamonitor
09 Feb 2011 $6400
Buy
Interactive Model
Interactive Model

Antidiabetics market forecast

Analysis of the competitive landscape and the recent changes in antidiabetics across seven major markets. Analysis of the threats to currently marketed drugs. Assessment of the opportunities available to novel agent classes.

Published By Datamonitor
17 Sep 2010 $15400
Buy
Interactive Model
Interactive Model

Antidyslipidemics Market Forecast

Forecast of the antidyslipidemic markets in the US, Japan, France, Germany, Italy, Spain, and the UK. Volume and revenue sales forecast to 2019.

Published By Datamonitor
23 Aug 2010 $15200
Buy
Interactive Model
Interactive Model

Asthma Market Forecast

This interactive model includes a 2012–21 patient-based forecast for asthma in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK).

Published By Datamonitor
07 Sep 2012 $6400
Buy
Interactive Model
Interactive Model

Asthma/COPD in Australia Market Forecast

In-depth overview and 10 year outlook for currently marketed and pipeline asthma/COPD products in Australia, examining both clinical and commercial factors driving product differentiation and uptake.

Published By Datamonitor
20 May 2010 $5700
Buy
Interactive Model
Interactive Model

Asthma/COPD Market Forecast

Asthma and COPD market forecast for the seven major markets, incorporating the latest data from the European Respiratory Society 2010 Congress. Recent advances and setbacks of marketed/pipeline products and generics companies' actions are covered.

Published By Datamonitor
29 Sep 2010 $15200
Buy
Interactive Model
Interactive Model

Commercial Insight: Cardiovascular and Metabolic Market Forecast

In-depth review of the cardiovascular and metabolic markets, including analysis and comparison of key sales trends in the therapy areas of diabetes, dyslipidemia, hypertension and thrombosis over the forecast (2010–19) period.

Published By Datamonitor
08 Feb 2011 $6400
Buy
Interactive Model
Interactive Model

COPD in China Forecast

Marketing synopsis: This interactive model includes 2011-20 forecast sales for chronic obstructive pulmonary disease (COPD) in China.

Published By Datamonitor
14 Dec 2011 $6400
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | » »|

No help is available.